
Linda Marbán, PhD, the CEO of Capricor Therapeutics, discussed future plans for the product after the promising data presented at MDA’s 2025 conference.
The CEO of Capricor Therapeutics
Linda Marbán, PhD, the CEO of Capricor Therapeutics, discussed future plans for the product after the promising data presented at MDA’s 2025 conference.
The CEO of Capricor Therapeutics discussed future plans for the product after the promising data presented at MDA’s 2025 conference.
Linda Marbán, PhD, the CEO of Capricor Therapeutics, discussed clinical data presented at MDA’s 2025 meeting.
The CEO of Capricor Therapeutics discussed clinical data presented at MDA’s 2025 meeting.